
Though ELISA tests are the gold
standard for diagnosing a whole slew of infectious diseases, the technology has
remained stuck within hospital labs.
The journal Science Translational Medicine reports that
the appliance, called a dongle, pulls its power from the smartphone and works
with a fingerprick of blood, much like a home diabetes blood glucose test.
Advertisement
Samuel K. Sia, associate professor of biomedical engineering at Columbia's School of Engineering and Applied Science Columbia University in New York and colleagues tested the device on 96 volunteers.
Such a combination immunoassay has not previously been
available in a unified test. It has already been trialed in field tests in
Rwanda on 96 people enrolled in disease transmission prevention programs and
volunteers in counseling and testing centers.
"It wasn't perfect, but worked almost as well as an expensive lab test to show who had active syphilis infections and who was infected with the human immunodeficiency virus (HIV) that causes AIDS," they said.
The device will cost roughly $34 to manufacture, orders of magnitude cheaper than conventional ELISA machines while providing similar accuracy of results.
The developers added, "We might be able to scale up HIV testing at the community level with immediate antiretroviral therapy that could nearly stop HIV transmissions and approach elimination of this devastating disease."
Source: Medindia
Advertisement
"It wasn't perfect, but worked almost as well as an expensive lab test to show who had active syphilis infections and who was infected with the human immunodeficiency virus (HIV) that causes AIDS," they said.
The device will cost roughly $34 to manufacture, orders of magnitude cheaper than conventional ELISA machines while providing similar accuracy of results.
The developers added, "We might be able to scale up HIV testing at the community level with immediate antiretroviral therapy that could nearly stop HIV transmissions and approach elimination of this devastating disease."
Source: Medindia
Advertisement
Advertisement
|
Advertisement
Recommended Reading
Latest AIDS/HIV News

In India, annual HIV infections and AIDS-related deaths continue to drop. Between 2010 and 2021, new HIV infections dropped by 46%.

Globally, all countries have promised to end AIDS by 2030, for which it is essential to safeguard individuals living with HIV to complete HIV care services.

How can you prevent HIV while breastfeeding? A monthly vaginal ring containing the antiretroviral drug dapivirine safely prevents HIV infection while breastfeeding.

Union Minister of State for Health Bharti Pravin Pawar had said that the government is providing free lifelong antiretroviral (ARV) medicines for people living with HIV.

Dr. Korosi said the goal to end AIDS by 2030 is badly off track, as inequalities, discrimination, and disregard for human rights are hampering our progress.